Human papillomavirus typing with a polymerase chain reaction-based genotyping array compared with type-specific PCR

Journal of Clinical Virology

Volumn 42, Issue 4, 2008, Pages 361-367

  Lin, Ching Yu ^a,b   Chao, Angel ^c   Yang, Yuh Cheng ^d   Chou, Hung Hsueh ^c   Ho, Chih Ming ^e   Lin, Ruey Wen ^b   Chang, Ting Chang ^c   Chiou, Jia Yia ^b   Chao, Fang Yu ^c   Wang, Kung Liahng ^d   Chien, Tsai Yen ^e   Hsueh, Swei ^c   Huang, Chu Chun ^c   Chen, Chien Jen ^f,g   Lai, Chyong Huey ^c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b King Car Food Industrial Co Ltd   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d MACKAY MEMORIAL HOSPITAL   (Taiwan)

^e CATHAY GENERAL HOSPITAL   (Taiwan)

^f GENOMICS RESEARCH CENTER   (Taiwan)

^g NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Agreement; HPV Blot; Human papillomavirus; Type specific PCR

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE;

ARTICLE; CANCER INVASION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 62; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN PAPILLOMAVIRUS TYPE 70; HUMAN PAPILLOMAVIRUS TYPE 71; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MY11/GP6+ POLYMERASE CHAIN REACTION; NONHUMAN; POLYMERASE CHAIN REACTION; POLYMERASE CHAIN REACTION BASED GENOTYPING ARRAY; PRIORITY JOURNAL; RELIABILITY; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS TYPING; WART VIRUS;

CERVIX UTERI; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 46149088452     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2008.03.018     Document Type: Article

References (15)

1. Castle P.E., Sadorra M., Garcia F., Holladay E.B., and Kornegay J. Pilot study of a commercialized human papillomavirus (HPV) genotyping assay: comparison of HPV risk group to cytology and histology. J Clin Microbiol 44 (2006) 3915-3917
2. de Cremoux P., Coste J., Sastre-Garau X., Thioux M., Bouillac C., Labbe S., et al. Efficiency of the hybrid capture 2 HPV DNA test in cervical cancer screening. A study by the French Society of Clinical Cytology. Am J Clin Pathol 120 (2003) 492-499
3. Gillio-Tos A., De Marco L., Ghisetti V., Snijders P.J., Segnan N., Ronco G., et al. Human papillomavirus typing with GP5+/6+ polymerase chain reaction reverse line blotting and with commercial type-specific PCR kits. J Clin Virol 36 (2006) 126-132
4. Huang H.J., Huang S.L., Lin C.Y., Lin R.W., Chao F.Y., Chen M.Y., et al. Human papillomavirus genotyping by a polymerase chain reaction-based genechip method in cervical carcinoma treated with neoadjuvant chemotherapy plus radical surgery. Int J Gynecol Cancer 14 (2004) 639-649
5. Huang S.L., Chao A., Hsueh S., Chao F.Y., Huang C.C., Yang J.E., et al. Comparison between the Hybrid Capture II Test and a SPF1/GP6+ PCR-based assay for detection of human papillomavirus DNA in cervical swab samples. J Clin Microbiol 44 (2006) 1733-1739
6. Kjaer S.K., van den Brule A.J., Paull G., Svare E.I., Sherman M.E., Thomsen B.L., et al. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ 325 (2002) 572
7. Lai C.H., Huang H.J., Hsueh S., Chao A., Lin C.T., Huang S.L., et al. Human papillomavirus genotype in cervical cancer: a population-based study. Int J Cancer 120 (2007) 1999-2006
8. Lin C.Y., Chen H.C., Lin R.W., You S.L., You C.M., Chuang L.C., et al. Quality assurance of genotyping array for detection and typing of human papillomavirus. J Virol Methods 140 (2007) 1-9
9. Meijer C.J., Snijders P.J., and Castle P.E. Clinical utility of HPV genotyping. Gynecol Oncol 103 (2006) 12-17
10. Molijn A., Kleter B., Quint W., and van Doorn L.J. Molecular diagnosis of human papillomavirus (HPV) infections. J Clin Virol 32 (2005) S43-S51
11. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348 (2003) 518-527
12. Poljak M., Marin I.J., Seme K., and Vince A. Hybrid Capture II HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail. J Clin Virol 25 (2002) S89-S97
13. Quint W.G., Pagliusi S.R., Lelie N., de Villiers E.M., and Wheeler C.M. Results of the first world health organization international collaborative study of detection of human papillomavirus DNA. J Clin Microbiol 44 (2006) 571-579
14. van Hamont D., van Ham M.A., Bakkers J.M., Massuger L.F., and Melchers W.J. Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the Roche linear array HPV genotyping test. J Clin Microbiol 44 (2006) 3122-3129
15. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 (1999) 12-19